In addition, we must be transparent and tell them we do not know effects on the human fetus, and it could be harmful, Hynes said
[DOI] [PMC free article] [PubMed] [Google Scholar] 2.Obi P.C., Njoku G.H., Mbaike A.C., Ihim A.C., Nwako O.F., Anyanwu A.C., Ohiri J.U., Nwazor E., Ubani B.C., Ogbonna S.U., et al
Still, there are key considerations to keep in mind
Combination Weight Loss (CagriSema) Extensive Research The Phase 3 REDEFINE 1 trial demonstrated that CagriSema (cagrilintide 2.4 mg plus semaglutide 2.4 mg) produced mean weight loss of 20.4% at 68 weeks in 3,417 adults with obesity or overweight without diabetes, compared to 14.9% with semaglutide alone, 11.5% with cagrilintide alone, and 3.0% with placebo